Tevogen Bio Holdings Inc (TVGN) Stock Price, Quote & News

Company Profile

Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in Phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 pat...

Industry: Biotechnology

Sector: Healthcare

Phone: 877 838 6434

Website: tevogen.com

Address:

15 Independence Boulevard, Suite #210, Warren, United States

stinstewart Jul. 1 at 6:49 PM

$TVGN https://www.globenewswire.com/news-release/2026/03/13/3255767/0/en/Tevogen-Reaffirms-Capital-Discipline-as-Lead-Investor-Maintains-Holdings-and-Company-Limits-Share-Utilization.html

0 · Reply

stinstewart Jul. 1 at 6:47 PM

$TVGN https://x.com/i/status/2072381998430122125

0 · Reply

MarketsParadise Jul. 1 at 5:43 PM

Small caps heating up, We are seeing some big runners lately. Take a look at ticker DRCT 💎 I believe this is the next monster runner waiting to be found: DRCT 💎 • 600K share float! • AI-powered digital advertising & marketing drive. • Extremely thin chart. • Any sustained buying pressure we look for the 5$+. $CDT $RNAZ $SSP $TVGN .12

0 · Reply

NGCS Jul. 1 at 2:46 PM

$PGY In 2 months it became true, so now it is time for $TVGN (IMO will become 12 usd in few days... exactly from $6 to 11,95$ again, getting a x2 --- 200%) NFA. Best regards!

0 · Reply

NGCS Jul. 1 at 9:21 AM

$TVGN Let’s look at the facts instead of the panic: $TVGN recently closed a private investment at $8.00/share. Today's drop under $6 on less than 5k volume is a classic liquidity trap, not a reflection of the company's real value. The quiet period is legally mandatory while the final MSO/CRO contracts are being drafted. If you liked the story at $8, this is just a technical gift created by short-term algorithm manipulation. Stay calm.

0 · Reply

NGCS Jul. 1 at 9:15 AM

$TVGN A falling stock price on microscopic volume doesn't mean a failing business. The $TVGN chart is bleeding purely due to a dry order book and algos walking the price down with a handful of shares. No new filings, no bankruptcy, no fundamental changes. Smart money knows the approved S-3 shelf is the runway for the $100M MSO deal. Ignore the daily noise, the structural thesis is intact. 🧘‍♂️💎 NFA

0 · Reply

bangbanga Jul. 1 at 5:16 AM

$TVGN This is a notorious scam company. They use shareholders as an endless ATM, keep diluting the stock without end, and continue scamming investors while draining every last dollar from them.

0 · Reply

NGCS Jun. 30 at 9:00 AM

$TVGN IMO friday and momday, Algos and shorts paper-handing over a standard S-3 shelf registration (thursday) tells you everything you need to know about market literacy. $TVGN didn’t dump on fundamentals; it got stop-loss hunted on microscopic volume. A shelf registration is a pre-approved toolkit for future MSO execution, not an immediate cash dump. The spring is coiled tight. Weak hands got shook, smart money averages down. 📉❌🚀 NFA

1 · Reply

TopSarge Jun. 29 at 8:25 PM

$TVGN This one just entered my watchlist

1 · Reply

MrAlientrader Jun. 29 at 7:26 PM

$TVGN looks no good, will just wait

0 · Reply

Tevogen files to sell 375,000 shares of common stock for holders

Jun 9, 2026, 3:30 PM EDT - 25 days ago

Tevogen Announces Formation of a Healthcare Services Initiative

2026-05-28T17:30:06.000Z - 5 weeks ago

Tevogen advances strategic acquisition initiatives

May 28, 2026, 12:30 PM EDT - 5 weeks ago

Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue

May 21, 2026, 12:15 PM EDT - 6 weeks ago

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization

May 18, 2026, 12:15 PM EDT - 6 weeks ago

Letter to Shareholders from CEO Dr. Ryan Saadi

2026-05-12T18:10:14.000Z - 7 weeks ago

Tevogen Bio Holdings Inc trading halted, volatility trading pause

2026-05-12T18:07:55.000Z - 7 weeks ago

Tevogen Bio Holdings Inc trading resumes

May 12, 2026, 11:45 AM EDT - 7 weeks ago

Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close

Apr 27, 2026, 11:50 AM EDT - 2 months ago

Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal

Mar 26, 2026, 12:45 PM EDT - 3 months ago

Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth

2026-03-25T18:25:30.000Z - 3 months ago

Tevogen regains compliance with Nasdaq minimum bid price requirement

Mar 25, 2026, 2:20 PM EDT - 3 months ago

Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement

Mar 18, 2026, 12:22 PM EDT - 3 months ago

Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)

Mar 13, 2026, 2:45 PM EDT - 4 months ago

Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization

2026-03-13T16:40:31.000Z - 4 months ago

Tevogen reports performance advancements for Tevogen.AI platform

Mar 13, 2026, 12:30 PM EDT - 4 months ago

Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure

Mar 11, 2026, 3:15 PM EDT - 4 months ago

Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform

2026-03-09T11:51:22.000Z - 4 months ago

Tevogen appoints interim leaders across core business verticals

Mar 9, 2026, 7:45 AM EDT - 4 months ago

Tevogen Names Leadership Team to Execute Diversified Growth Strategy

2026-03-06T20:45:38.000Z - 4 months ago

Tevogen CEO says ‘actively evaluating potential acquisitions’

2026-03-06T15:20:39.000Z - 4 months ago

Tevogen Bio Holdings Inc trading resumes

2026-03-06T15:15:32.000Z - 4 months ago

Tevogen Bio Holdings Inc trading halted, volatility trading pause

2026-03-06T00:51:12.000Z - 4 months ago

Tevogen Bio Holdings Inc trading halted, news pending

2026-03-05T20:00:17.000Z - 4 months ago

Tevogen signs LOI to evaluate potential acquisition of Apozeal Pharmaceutical

Mar 5, 2026, 2:50 PM EST - 4 months ago

Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical

2026-03-04T14:23:36.000Z - 4 months ago

Tevogen downgraded to Hold from Buy at D. Boral Capital

2026-03-04T13:13:07.000Z - 4 months ago

Tevogen announces 50-for-1 reverse stock split

Mar 4, 2026, 8:00 AM EST - 4 months ago

Tevogen Announces Reverse Stock Split

2026-02-27T19:25:58.000Z - 4 months ago

Tevogen signs LoI to evaluate acquisition of contract research organization

Feb 27, 2026, 2:20 PM EST - 4 months ago

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization

Feb 26, 2026, 4:22 PM EST - 4 months ago

UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus

2026-02-26T14:39:08.000Z - 4 months ago

Tevogen signs non-binding LOI to evaluate acquisition of Sciometrix

Feb 26, 2026, 9:20 AM EST - 4 months ago

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus

2026-01-30T20:05:31.000Z - 5 months ago

Tevogen to evaluate potential one-time special cash dividend

Jan 30, 2026, 3:00 PM EST - 5 months ago

Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders

Jan 29, 2026, 2:45 PM EST - 5 months ago

Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue

2026-01-12T14:11:33.000Z - 6 months ago

Tevogen reports scientific, operational milestones achieved in 2025

Jan 12, 2026, 9:00 AM EST - 6 months ago

Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025

Dec 22, 2025, 12:40 PM EST - 6 months ago

Tevogen CEO Donates Shares to Support Education for Underprivileged Children

Dec 19, 2025, 11:10 AM EST - 7 months ago

Tevogen CEO Donates Personal Shares to Support Local Fire Department

Dec 11, 2025, 3:15 PM EST - 7 months ago

Tevogen CEO Supports Local Law Enforcement with Personal Contribution of 230,000 Company's Shares of Common Stock

Dec 9, 2025, 2:20 PM EST - 7 months ago

Tevogen Celebrates Board Member Dr. Curtis Patton, Honored by Yale University for Distinguished Career and Lasting Contributions to Medical Education and Equity in Medicine

Dec 8, 2025, 2:50 PM EST - 7 months ago

Tevogen Recognized on 2025 NJBIZ Power List Amid Growth and Multi-Billion-Dollar Revenue Outlook

Nov 14, 2025, 2:32 PM EST - 8 months ago

Tevogen Highlights Continued Capital Efficiency Following Filing of Q3 2025 Form 10-Q

2025-11-05T20:25:58.000Z - 8 months ago

Tevogen announces clinical milestone in evolution of ExacTcell platform

Nov 5, 2025, 3:20 PM EST - 8 months ago

Tevogen Reports Major Clinical Milestone: Expands HLA Coverage of its Investigational Precision T Cell Therapy for Acute and Long COVID

Nov 3, 2025, 2:45 PM EST - 8 months ago

Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn

Oct 29, 2025, 12:35 PM EDT - 8 months ago

Tevogen Senior Management Engages with Business and Community Leaders and Highlights Recent Progress

Oct 15, 2025, 3:50 PM EDT - 9 months ago

Tevogen Updates on TVGN 489 Following Growing Long COVID Patient Interest

Sep 25, 2025, 8:30 AM EDT - 10 months ago

Tevogen Marks Major Milestone in Its AI Initiative to Enhance Efficacy of T Cell–Based Therapies with 100x PredicTcell™ Beta Data Expansion

Sep 23, 2025, 8:30 AM EDT - 10 months ago

Tevogen Highlights Potential Role of TVGN 489 in Eliminating Persistent Viral Reservoirs Linked to Long COVID

Sep 19, 2025, 3:40 PM EDT - 10 months ago

Tevogen Commends HHS for Addressing Long COVID, Emphasizes TVGN 489's Potential Impact for 20 Million Americans

Sep 10, 2025, 11:59 AM EDT - 10 months ago

Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Join Startup Forum Panel at Databricks DATA + AI World Tour in Boston

Sep 9, 2025, 3:15 PM EDT - 10 months ago

Tevogen Estimates 5-Year Top-Line Revenue of ∼$6.5 Billion For Product Focused on Liver Cancer Prevention with High-Risk Chronic Hepatitis B Infection

Sep 8, 2025, 9:27 AM EDT - 10 months ago

Tevogen Values TVGN-489 at $9–$11 Billion rNPV, Its First Clinical Product From the Proprietary ExacTcell™ Allogeneic T Cell Platform

Sep 4, 2025, 3:48 PM EDT - 10 months ago

Tevogen Shares Valuation of Key Assets and Potential Forecast For Pipeline Product Focused on EBV Associated Leukemia and Lymphomas

Sep 3, 2025, 4:15 PM EDT - 10 months ago

Tevogen Underscores the Importance of Precision Immunotherapies, Including TVGN 489 for Vulnerable Individuals Infected with SARS-CoV-2

Aug 27, 2025, 3:20 PM EDT - 11 months ago

Tevogen Bio Highlights Proprietary Assets and Upcoming Valuation Disclosure

Aug 26, 2025, 2:50 PM EDT - 11 months ago

Tevogen Expresses Gratitude to Yale for Recognition of Dr. Ryan Saadi and Company's Mission of Health Equity

Aug 25, 2025, 3:10 PM EDT - 11 months ago

Tevogen Sees Continued Growth in Institutional Ownership in Q2 2025; 72% of Holders Increased or Maintained Positions

Aug 22, 2025, 3:25 PM EDT - 11 months ago

Tevogen Recognized in BINJE's BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma

Aug 19, 2025, 3:40 PM EDT - 11 months ago

REPEAT -- Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts

Aug 19, 2025, 12:10 PM EDT - 11 months ago

Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum

Aug 18, 2025, 5:50 PM EDT - 11 months ago

Tevogen CEO Donates Personal Shares to Support Local Law Enforcement

Aug 18, 2025, 5:15 PM EDT - 11 months ago

Tevogen CEO Donates Personal Shares to Support Brain Injury Recovery

Aug 14, 2025, 3:55 PM EDT - 11 months ago

Tevogen to Release Internal Asset Valuation; CEO Affirms Assets Are Fully Protected

Aug 13, 2025, 3:53 PM EDT - 11 months ago

Repeat - Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology

Aug 11, 2025, 3:45 PM EDT - 11 months ago

Tevogen Bio Reaffirms Investor Confidence with Estimated Asset Value Exceeding $10 Billion

stinstewart Jul. 1 at 6:49 PM

$TVGN https://www.globenewswire.com/news-release/2026/03/13/3255767/0/en/Tevogen-Reaffirms-Capital-Discipline-as-Lead-Investor-Maintains-Holdings-and-Company-Limits-Share-Utilization.html

0 · Reply

stinstewart Jul. 1 at 6:47 PM

$TVGN https://x.com/i/status/2072381998430122125

0 · Reply

MarketsParadise Jul. 1 at 5:43 PM

0 · Reply

NGCS Jul. 1 at 2:46 PM

$PGY In 2 months it became true, so now it is time for $TVGN (IMO will become 12 usd in few days... exactly from $6 to 11,95$ again, getting a x2 --- 200%) NFA. Best regards!

0 · Reply

NGCS Jul. 1 at 9:21 AM

0 · Reply

NGCS Jul. 1 at 9:15 AM

0 · Reply

bangbanga Jul. 1 at 5:16 AM

$TVGN This is a notorious scam company. They use shareholders as an endless ATM, keep diluting the stock without end, and continue scamming investors while draining every last dollar from them.

0 · Reply

NGCS Jun. 30 at 9:00 AM

1 · Reply

TopSarge Jun. 29 at 8:25 PM

$TVGN This one just entered my watchlist

1 · Reply

MrAlientrader Jun. 29 at 7:26 PM

$TVGN looks no good, will just wait

0 · Reply

robsmi63 Jun. 29 at 6:46 PM

$VTGN $TVGN which gets to 10 billion first? Huh, Saadi?

0 · Reply

Somerandomnoname Jun. 29 at 2:19 PM

$TVGN just another chance to get a seat if you can at a good price

0 · Reply

NGCS Jun. 29 at 2:12 PM

$TVGN I guess you are a bot...only 0 followers and 0 following...only I gues...

1 · Reply

thegreatone24 Jun. 29 at 1:59 PM

$TVGN So I guess it wasn’t just a stop loss raid smh

0 · Reply

NGCS Jun. 27 at 7:37 AM

$TVGN IMO brutal stop loss hunting this friday. Last 10 minutes before market close, stock price was 9,17 usd/sh (only 4.000 shares traded in the sesion), and in few minutes there were 80.000 shares traded at 8,37-7,89 and lead with only 4 shares at 7 usd/sh. After market lead stock price to 7,50 usd/sh. Last days I tried to buy shares at 9,50 usd and there was no share to fill my orders (only at 10,11 usd I could few of them). Anyway management should hurry up with contracts signing (PR and SEC 8-K filing) in order not to allow more of this. Best regards. NFA.

0 · Reply

Somerandomnoname Jun. 26 at 8:38 PM

$TVGN my opinion thats a good price. too bad for me I wasn't watching for it. I am sorta tied up with other things for the foreseeable future. As best I can tell anything below 8 is good to go.

0 · Reply

Lifefinder Jun. 26 at 8:08 PM

$TVGN what happened ?

3 · Reply

NGCS Jun. 25 at 4:25 PM

$TVGN tic tac … https://x.com/tevogenbio/status/2070154697416077621?s=46

0 · Reply

SuperGreenToday Jun. 17 at 12:03 PM

$TVGN

0 · Reply

NGCS Jun. 9 at 8:51 PM

$TVGN Today's PR confirms the master plan is moving fast. The new Healthcare Services division led by VP William Keane is officially created to evaluate and integrate the MSO and CRO acquisitions. CFO Kirti Desai explicitly reiterated the $100M potential combined annual revenue. This isn't just talk; they are building the structure to handle the cash flow before the definitive agreements drop on the SEC.

0 · Reply

NGCS Jun. 9 at 8:49 PM

$TVGN Official PR just dropped! 🚨 They officially announced the formation of the Healthcare Services Initiative led by William Keane. Connect the dots people: This is the exact internal corporate infrastructure being built to absorb the MSO & CRO acquisitions. They are literally setting up the house for that incoming $100M annual revenue. Healthy consolidation today holding the $10+ psychological support while shorts tried to play games. The micro-float is locked, the fundamentals are aligning, and the official 8-K contracts signing is the next logical step. 🚀🔥 #Bullish #LowFloat NFA

0 · Reply

focafoca99 Jun. 9 at 7:51 PM

$TVGN created a new healthcare services initiative to explore MSO and CRO acquisitions targeting $100 million in annual revenue.

0 · Reply

Market Cap	24.16M
Revenue (ttm)	0.00
Net Income (ttm)	-26.28M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	-0.65

Volume	12,800
Avg Vol	29,740
Day's Range	N/A - N/A
Shares Out	4.19M
Stochastic %K	5%
Beta	0.20
Analysts	Strong Buy
Price Target	$100.00